Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:ANTX

(ANTX) (ANTX) Stock Price, News & Analysis

(ANTX) logo

About (ANTX) Stock (NYSE:ANTX)

Advanced Chart

Key Stats

Today's Range
$1.22
$1.26
50-Day Range
N/A
52-Week Range
$0.87
$2.95
Volume
83,337 shs
Average Volume
361,139 shs
Market Capitalization
$32.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.50
Consensus Rating
Hold

Company Overview

Receive ANTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTX) and its competitors with MarketBeat's FREE daily newsletter.

ANTX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
AN2 Therapeutics, Inc. (ANTX) Receives a Sell from Evercore ISI
Evercore ISI Reaffirms Their Sell Rating on AN2 Therapeutics, Inc. (ANTX)
See More Headlines

ANTX Stock Analysis - Frequently Asked Questions

(ANTX) (NYSE:ANTX) announced its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.48) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.59) by $0.11.

(ANTX) (ANTX) raised $69 million in an initial public offering on Friday, March 25th 2022. The company issued 4,600,000 shares at a price of $14.00-$16.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that (ANTX) investors own include Broadcom (AVGO), NVIDIA (NVDA), Adobe (ADBE), CrowdStrike (CRWD), Meta Platforms (META), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
8/13/2024
Today
7/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:ANTX
Previous Symbol
NASDAQ:ANTX
CIK
1156093
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$2.00
Low Price Target
$1.00
Potential Upside/Downside
+36.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.73 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-57.62%
Return on Assets
-52.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.75
Quick Ratio
9.75

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.19 per share
Price / Book
0.26

Miscellaneous

Outstanding Shares
29,880,000
Free Float
23,667,000
Market Cap
$32.87 million
Optionable
Not Optionable
Beta
0.15
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:ANTX) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners